The effect of triple-dose-intravenous tranexamic acid on blood loss in patients undergoing total hip arthroplasty without affecting blood coagulopathy: A prospective thromboelastographic analysis
Acta Orthopaedica et Traumatologica Turcica · 21.11.2023 · 57 (6) · 378-383
DOI: 10.5152/j.aott.2023.23001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Orthopaedica et Traumatologica Turcica, online erschienen am 21.11.2023. Verfasst von Wang-Yi Jin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Republic of China. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Objective
This study aimed to assess the safety and efficacy of triple-dose intravenous tranexamic acid (TXA) in patients following total hip arthroplasty (THA) using thromboelastography (TEG).
Methods
One hundred thirty patients undergoing THA were prospectively enrolled in the study. According to the intravenous infusion TXA dose, patients were divided into single-dose (n=65; mean age=60.8 ± 8.1 years) and triple-dose groups (n=65; mean age=61.8 ± 8.6 years). Complete blood count (CBC), conventional coagulation tests (CCT), and TEG were conducted 1 day before the operation, on postoperative day 1 (POD1), and postoperative day 7 (POD7). Color Doppler ultrasonography was performed 1 day before the operation and on POD7. Drainage blood loss, total blood loss (TBL), hidden blood loss (HBL), deep vein thrombosis (DVT) incidence, and blood transfusion rates were calculated and recorded. The CCT, CBC, and TEG parameters were compared between the 2 groups.
Results
Single- and triple-dose groups had significantly different hematocrit on POD7 (P < .05). No significant differences were found in CCT and hemoglobin at any corresponding time point between the 2 groups (P > .05). Despite the reaction time (R) on POD1 (P < .05), there were no significant differences in other TEG parameters at any other time point between the 2 groups (P > 0.05). For drainage blood loss and TBL, the triple-dose group had lesser blood loss than the single-dose group (P < .05). However, no significant differences were found for blood transfusion rate, HBL, or incidence of DVT (P > .05).
Conclusion
Compared with single-dose, triple-dose TXA can be more effective in decreasing blood loss without increasing DVT incidence in patients undergoing THA. Although there is a notable disparity in the R time on POD1, the administration of triple-dose TXA does not substantially impact the coagulation status as assessed by TEG and CCT. Cite this article as: Jin W-y, Yan Z-w, Zhang X, et al. The effect of triple-dose-intravenous tranexamic acid on blood loss in patients undergoing total hip arthroplasty without affecting blood coagulopathy: A prospective thromboelastographic analysis. Acta Orthop Traumatol Turc., 2023;57(6):378-383.
Autor:innen und Institutionen
- Department of Orthopaedics, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Republic of China.
- Department of Orthopaedics, Changzhou Jintan First People's Hospital, Changzhou, Republic of China.
- Department of Orthopaedics, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Republic of China; Department of Orthopaedics, Changzhou Jintan First People's Hospital, Changzhou, Republic of China.
- Department of Orthopaedics, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Republic of China; Department of Orthopaedics, Zhujiang Hospital of Southern Medical University, Guangzhou, Republic of China.
Zitieren
APA
Jin, W. Y., Yan, Z. W., Zhang, X., Pan, S., Huang, C. R., Guo, K. J., & Zheng, X. (2023). The effect of triple-dose-intravenous tranexamic acid on blood loss in patients undergoing total hip arthroplasty without affecting blood coagulopathy: A prospective thromboelastographic analysis. Acta Orthopaedica et Traumatologica Turcica, 57(6), 378-383. https://doi.org/10.5152/j.aott.2023.23001
Vancouver
Jin WY, Yan ZW, Zhang X, Pan S, Huang CR, Guo KJ, et al. The effect of triple-dose-intravenous tranexamic acid on blood loss in patients undergoing total hip arthroplasty without affecting blood coagulopathy: A prospective thromboelastographic analysis. Acta Orthopaedica et Traumatologica Turcica. 2023;57(6):378-383. doi:10.5152/j.aott.2023.23001
BibTeX
@article{Jin2023,
author = {Jin, Wang-Yi and Yan, Zi-Wen and Zhang, Xing and Pan, Sheng and Huang, Chao-Ran and Guo, Kai-Jin and Zheng, Xin},
title = {The effect of triple-dose-intravenous tranexamic acid on blood loss in patients undergoing total hip arthroplasty without affecting blood coagulopathy: A prospective thromboelastographic analysis},
journal = {Acta Orthopaedica et Traumatologica Turcica},
year = {2023},
volume = {57},
number = {6},
pages = {378--383},
doi = {10.5152/j.aott.2023.23001}
}
EUVIMED